KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 26th Apr 2024 ASND stock ended at $135.90. This is 0.752% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.81% from a day low at $133.39 to a day high of $139.81.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Feb 14, 2023 $113.45 $114.74 $110.65 $111.00 162 344
Feb 13, 2023 $113.51 $115.39 $113.39 $113.89 114 177
Feb 10, 2023 $117.90 $119.54 $113.02 $113.95 380 685
Feb 09, 2023 $116.01 $119.23 $113.29 $118.42 243 711
Feb 08, 2023 $115.57 $117.64 $113.84 $114.58 175 473
Feb 07, 2023 $113.73 $117.00 $112.12 $116.35 386 001
Feb 06, 2023 $114.74 $116.53 $113.80 $114.15 193 543
Feb 03, 2023 $116.89 $119.48 $115.08 $116.10 126 947
Feb 02, 2023 $124.22 $124.65 $116.49 $117.74 276 550
Feb 01, 2023 $125.01 $125.18 $120.05 $123.50 156 596
Jan 31, 2023 $120.74 $124.29 $120.74 $124.08 141 200
Jan 30, 2023 $122.50 $123.50 $120.00 $120.80 359 051
Jan 27, 2023 $121.50 $124.38 $118.01 $122.50 153 978
Jan 26, 2023 $121.06 $122.59 $119.22 $121.53 119 870
Jan 25, 2023 $120.70 $122.00 $118.31 $119.90 142 433
Jan 24, 2023 $123.42 $124.65 $120.69 $122.39 460 675
Jan 23, 2023 $122.83 $124.29 $120.66 $123.79 234 409
Jan 20, 2023 $122.48 $124.31 $121.39 $123.02 236 600
Jan 19, 2023 $120.08 $121.72 $117.31 $121.51 302 000
Jan 18, 2023 $119.81 $123.15 $118.92 $119.86 282 400
Jan 17, 2023 $115.00 $122.15 $114.88 $119.65 219 731
Jan 13, 2023 $117.71 $120.85 $115.03 $115.03 385 167
Jan 12, 2023 $114.17 $119.44 $113.80 $117.91 370 817
Jan 11, 2023 $113.54 $117.12 $111.63 $113.64 353 105
Jan 10, 2023 $108.07 $113.08 $108.07 $112.61 385 100
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT